Gene replacement in mutant marrow cells is a potential treatment modality for heritable disorders of the blood forming tissues and for specific metabolic diseases. A major problem with bone marrow transfer therapy is our incomplete understanding of the injected stem cells' fate. This is critical following virus mediated gene therapy where active clones appear to be lost or suppressed. While the mouse is an excellent model in which to assess stem cell biology, events occurring after marrow transplantation have, of necessity, been assayed not in situ but either in vitro or in a secondary host. We have, until recently, lacked a good model in which host and donor cells are distinguishable. We are studying a mouse model of the human lysosomal storage disease Mucopolysaccharidosis Type VII, MPS VII, that lends itself to the direct in vivo analysis of normal and virus transduced MPS VII stem cells. The MPS VII mice lack the enzyme beta- glucuronidase but all +/+ donor cells (except erythrocytes) and MPS VII cells that are transduced to produce beta-glucuronidase are recognized by their intense histochemical staining against a null background. Our goals are to understand the fate of the injected cells, to assess cell lineages derived from them, and to examine virus transduced cells for continuing beta-glucuronidase production.
The Specific Aims are: To establish the sites where injected +/+ hematopoietic cells either from whole marrow or from marrow highly enriched for stem cells seed in the MPS VII recipient; To identify in vivo the immediate progeny of the cells in Aim 1; To assess the long term distribution of the donor progeny in peripheral blood and various organs of the beta-glucuronidase deficient mice; To determine the relative numbers of donor autologous MPS VII stem cells that are transduced by exposure to virus carrying the rat beta- glucuronidase cDNA and to assess their production of beta-glucuronidase in vivo; and To monitor the long term production of beta-glucuronidase in virus transduced cells in the various MPS VII tissues. Results address hypotheses concerning seeding site preference, inter-site migration, position-and time-dependent differentiation, lineage complexity, and long term function of transduced genes, impossible to assess directly until now.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK027726-12A1
Application #
2138048
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1980-12-01
Project End
1999-03-31
Budget Start
1995-04-12
Budget End
1996-03-31
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Ohgami, Robert S; Campagna, Dean R; Antiochos, Brendan et al. (2005) nm1054: a spontaneous, recessive, hypochromic, microcytic anemia mutation in the mouse. Blood 106:3625-31
Vogler, Carole; Levy, Beth; Galvin, Nancy et al. (2005) Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse. Pediatr Dev Pathol 8:453-62
Barker, Jane E; Deveau, Susan A; Compton, Sheila T et al. (2005) High incidence, early onset of histiocytic sarcomas in mice with Hertwig's anemia. Exp Hematol 33:1118-29
Soper, Brian W; Duffy, Ted M; Lessard, Mark D et al. (2004) Transplanted ER-MP12hi20-58med/hi myeloid progenitors produce resident macrophages from marrow that are therapeutic for lysosomal storage disease. Blood Cells Mol Dis 32:199-213
Schuldt, A J T; Hampton, T J; Chu, V et al. (2004) Electrocardiographic and other cardiac anomalies in beta-glucuronidase-null mice corrected by nonablative neonatal marrow transplantation. Proc Natl Acad Sci U S A 101:603-8
Barker, Jane E; Schuldt, Adam J T; Lessard, Mark L et al. (2003) Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII. Exp Hematol 31:1112-8
Barker, J E; Schuldt, A J T; Lessard, M D et al. (2003) Donor cell replacement in mice transplanted in utero is limited by immune-independent mechanisms. Blood Cells Mol Dis 31:291-7
Soper, Brian W; Lessard, Mark D; Jude, Craig D et al. (2002) Delayed administration of carrier marrow can decrease competition on donor stem cells during engraftment and maintain radioprotection of the host. Exp Hematol 30:837-45
Soper, B W; Lessard, M D; Vogler, C A et al. (2001) Nonablative neonatal marrow transplantation attenuates functional and physical defects of beta-glucuronidase deficiency. Blood 97:1498-504
Donsante, A; Vogler, C; Muzyczka, N et al. (2001) Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther 8:1343-6

Showing the most recent 10 out of 36 publications